Baudax Bio DSO Ratio 2011-2026 | BXRX

Annual DSO Ratio Baudax Bio

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
126	100	37.8	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Maximum	Minimum	Average
126	37.8	88

2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	178	186	124	-	104	86.7	49.3	-	68.4	13.3	28.6	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Maximum	Minimum	Average
186	13.3	93.2

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
Alterity Therapeutics Limited ATHE	16.2 K	$ 3.5	-5.79 %	$ 8.42 B	Australia
I-Mab IMAB	271	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	84.7	-	-	$ 40.3 B	USA
EyeGate Pharmaceuticals, Inc. EYEG	2.75 K	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	204	-	-18.52 %	$ 27.3 M	Britain
Amphastar Pharmaceuticals AMPH	70.9	$ 20.22	-0.76 %	$ 945 M	USA
Acorda Therapeutics ACOR	48.3	-	-24.86 %	$ 820 K	USA
Adverum Biotechnologies ADVM	222	-	-	$ 86.2 M	USA
Advaxis ADXS	88.1	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	146	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	186	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	216	-	-	$ 1.01 B	USA
Akebia Therapeutics AKBA	62.9	$ 1.39	-0.43 %	$ 357 M	USA
Applied Genetic Technologies Corporation AGTC	0.114	-	-	$ 26.5 M	USA
Aptinyx APTX	46.9	-	-39.0 %	$ 4.57 M	USA
Can-Fite BioPharma Ltd. CANF	28.1	$ 2.99	2.4 %	$ 4.92 M	Israel
Aquestive Therapeutics AQST	103	$ 4.13	1.23 %	$ 442 M	USA
Aravive ARAV	16.8	-	-13.39 %	$ 1.45 M	USA
Arcutis Biotherapeutics ARQT	106	$ 24.23	0.08 %	$ 3.08 B	USA
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
Celldex Therapeutics CLDX	321	$ 32.58	1.05 %	$ 2.16 B	USA
Autolus Therapeutics plc AUTL	58.2	$ 1.5	0.34 %	$ 399 M	Britain
Cidara Therapeutics CDTX	2.26 K	-	-	$ 1.41 B	USA
Ayala Pharmaceuticals AYLA	61.7	-	-	$ 7.46 M	Israel
Aytu BioScience AYTU	150	$ 2.55	-	$ 16 M	USA
CureVac N.V. CVAC	13.6	-	-	$ 867 M	Germany
BeiGene, Ltd. BGNE	52.6	-	0.49 %	$ 251 B	Cayman-islands
Alpine Immune Sciences ALPN	154	-	-	$ 2.17 B	USA
CymaBay Therapeutics CBAY	182	-	-	$ 3.45 B	USA